Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Patterson

Showing results (1061-1070 of 1,173) with videos related to

Pageof 118
Sort By:
The Journal of Urology|May 1, 1997
Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockadeP F Schellhammer, P Venner, G P Haas, et al.
The Canadian Journal of Urology|September 26, 2008
Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancerChristopher J DiBlasio, Jessica Hammett, John B Malcolm, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Factors Associated with COVID-19 Testing among People who Inject Drugs: Missed Opportunities for Reaching those Most at RiskSamantha Yeager, Daniela Abramovitz, Alicia Harvey-Vera, et al.
Schizophrenia Research|September 24, 2013
Validation of a European Spanish-version of the University of California performance Skills Assessment (Sp-UPSA) in patients with schizophrenia and bipolar disorderMaria P Garcia-Portilla, Jesus J Gomar, Maria T Bobes-Bascaran, et al.
Substance Use & Misuse|April 6, 2017
Lifetime Doctor-Diagnosed Mental Health Conditions and Current Substance Use Among Gay and Bisexual Men Living in Vancouver, CanadaNathan J Lachowsky, Joshun J S Dulai, Zishan Cui, et al.
Biochemistry|March 5, 2003
A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema variumHeidi R Bokesch, Barry R O'Keefe, Tawnya C McKee, et al.
The Prostate|July 27, 1999
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study GroupD G McLeod, P F Schellhammer, N J Vogelzang, et al.
Urology|July 23, 2011
Comparison of rates and risk factors for development of osteoporosis and fractures after radical or partial nephrectomyAditya Bagrodia, Reza Mehrazin, Wassim M Bazzi, et al.
BMC Genomics|April 12, 2013
Reevaluation of the evolutionary events within recA/RAD51 phylogenySree V Chintapalli, Gaurav Bhardwaj, Jagadish Babu, et al.
Journal of Affective Disorders|January 22, 2019
A longitudinal analysis of cannabis use and mental health symptoms among gay, bisexual, and other men who have sex with men in Vancouver, CanadaFrank Y Chou, Heather L Armstrong, Lu Wang, et al.
Pageof 118

Showing results (1061-1070 of 1,173) with videos related to

Sort By:
Pageof 118
The Journal of Urology|May 1, 1997
Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockadeP F Schellhammer, P Venner, G P Haas, et al.
The Canadian Journal of Urology|September 26, 2008
Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancerChristopher J DiBlasio, Jessica Hammett, John B Malcolm, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Factors Associated with COVID-19 Testing among People who Inject Drugs: Missed Opportunities for Reaching those Most at RiskSamantha Yeager, Daniela Abramovitz, Alicia Harvey-Vera, et al.
Schizophrenia Research|September 24, 2013
Validation of a European Spanish-version of the University of California performance Skills Assessment (Sp-UPSA) in patients with schizophrenia and bipolar disorderMaria P Garcia-Portilla, Jesus J Gomar, Maria T Bobes-Bascaran, et al.
Substance Use & Misuse|April 6, 2017
Lifetime Doctor-Diagnosed Mental Health Conditions and Current Substance Use Among Gay and Bisexual Men Living in Vancouver, CanadaNathan J Lachowsky, Joshun J S Dulai, Zishan Cui, et al.
Biochemistry|March 5, 2003
A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema variumHeidi R Bokesch, Barry R O'Keefe, Tawnya C McKee, et al.
The Prostate|July 27, 1999
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study GroupD G McLeod, P F Schellhammer, N J Vogelzang, et al.
Urology|July 23, 2011
Comparison of rates and risk factors for development of osteoporosis and fractures after radical or partial nephrectomyAditya Bagrodia, Reza Mehrazin, Wassim M Bazzi, et al.
BMC Genomics|April 12, 2013
Reevaluation of the evolutionary events within recA/RAD51 phylogenySree V Chintapalli, Gaurav Bhardwaj, Jagadish Babu, et al.
Journal of Affective Disorders|January 22, 2019
A longitudinal analysis of cannabis use and mental health symptoms among gay, bisexual, and other men who have sex with men in Vancouver, CanadaFrank Y Chou, Heather L Armstrong, Lu Wang, et al.
Pageof 118